Results 111 to 120 of about 117,034 (131)
Some of the next articles are maybe not open access.

Brain metastases

Current Treatment Options in Neurology, 2008
Metastatic brain tumors are the most common intracranial neoplasm in adults, affecting up to 10% of adults with cancer in the United States. The risk of developing brain metastases varies by primary cancer type, with lung cancer, breast cancer, and melanoma accounting for the majority.
April F, Eichler, Scott R, Plotkin
openaire   +2 more sources

Brain metastases

Neurologic Clinics, 2003
Brain metastases are one of the most feared complications of cancer because even small tumors may cause incapacitating neurologic symptoms. This article reviews the epidemiology, clinical features, treatment, and prognosis of brain metastases from system malignancies.
Andrew B, Lassman, Lisa M, DeAngelis
openaire   +3 more sources

Brain metastases

Current Treatment Options in Oncology, 2000
Brain metastases are an increasingly common complication in patients with systemic cancer. The optimal treatment for each patient depends on careful evaluation of several factors: the location, size, and number of brain metastases; the patient's age, general condition, and neurologic status; and the extent of systemic cancer to name a few. For patients
P Y, Wen, J S, Loeffler
openaire   +2 more sources

Brain metastases

Current Treatment Options in Oncology, 2001
Metastatic tumors to the brain are an increasing cause of morbidity and mortality in patients with systemic cancers. Many new therapies used to treat systemic cancers do not penetrate the central nervous system (CNS) and do not protect patients from the development of brain metastases.
M G, Ewend   +4 more
openaire   +2 more sources

Brain Metastases

Neurologic Clinics, 2007
Brain metastases are a common complication of cancer and alter patient management more than metastases at any other site of distant progression. Supportive therapies include steroids and antiseizure medications. Definitive treatments include radiation therapy, surgery, and chemotherapy.
Teri D, Nguyen, Lisa M, DeAngelis
openaire   +2 more sources

Nonenhancing Brain Metastases

Journal of Neuroimaging, 2011
The hallmark radiological finding in metastatic brain disease is multiple enhancing lesions. We report a case of metastatic lung cancer to the brain with a lack of contrast enhancement. We believe that this unusual finding is due to inadvertent "treatment" of the metastases with the antiangiogenic agent bevacizumab (Avastin).
Sasan, Karimi   +4 more
openaire   +2 more sources

Resectable Brain Metastases

Journal of Clinical Oncology, 2006
Brain metastases are the most common brain tumors seen in clinical practice, comprising well over half of all brain tumors. For many years, surgical resection of brain metastases was considered a form of palliative therapy only, but more recently it has been shown to have a more important role in extending survival in appropriately selected patients ...
Michael A, Vogelbaum, John H, Suh
openaire   +2 more sources

Recurrent Brain Metastases

Neurosurgery Clinics of North America, 1996
Metastases of the brain are the most frequent metastatic neurologic complication of systemic cancer and are second only to metabolic encephalopathies as a cause of central nervous system dysfunction in cancer patients. Despite recent significant advances in the diagnosis and treatment of metastases to the brain, many patients will suffer from ...
E, Alexander, J S, Loeffler
openaire   +2 more sources

Brain metastases: radiosurgery

2018
Stereotactic radiosurgery has revolutionized the management of brain metastases. It delivers focused, highly conformal, ionizing radiation to a tumor delineated using high-resolution imaging, with low toxicity to adjacent brain structures. Randomized controlled and prospective trials have demonstrated a survival advantage and high local control rates ...
Amparo, Wolf, Douglas, Kondziolka
openaire   +2 more sources

[Brain metastases].

Pneumologie (Stuttgart, Germany)
Cerebral metastases in patients with metastatic lung cancer are found in more than 30% of patients at baseline and manifest themselves in two out of three patients during disease evolution. For a long time, the cerebral manifestation of the disease was classified as prognostically unfavorable and hence such patients were regularly excluded from therapy
Christian, Schulz   +4 more
  +6 more sources

Home - About - Disclaimer - Privacy